Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    9875874 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Secondary Prevention of Osteoporosis
Condition: Osteoporosis
Interventions: Drug: alendronate with cholecalciferol;   Drug: calcium carbonate with cholecalciferol;   Behavioral: Falls prevention measures
2 Completed FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)
Condition: Osteoporosis, Postmenopausal
Interventions: Drug: MK0217, alendronate sodium / Duration of Treatment : 5 Years;   Drug: Comparator : placebo (unspecified) /Duration of Treatment : 5 Years

Study has passed its completion date and status has not been verified in more than two years.